These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 34019956)

  • 1. Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular Degeneration.
    Singer M; Singh RP; Gibson A; Moini H; Reed K; Vitti R; Du W; Eichenbaum D
    Ophthalmology; 2021 Nov; 128(11):1657-1660. PubMed ID: 34019956
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Ying GS; VanderBeek BL
    Lancet; 2024 Jul; 404(10447):4-5. PubMed ID: 38876134
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT; Omizo JN; Kokame KA; Yamane ML
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy.
    Zarbin MA; Hill L; Maunz A; Gliem M; Stoilov I
    Br J Ophthalmol; 2022 Nov; 106(11):1561-1566. PubMed ID: 34039560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACILLARY LAYER DETACHMENT: MULTIMODAL IMAGING AND HISTOLOGIC EVIDENCE OF A NOVEL OPTICAL COHERENCE TOMOGRAPHY TERMINOLOGY: Literature Review and Proposed Theory.
    Ramtohul P; Engelbert M; Malclès A; Gigon E; Miserocchi E; Modorati G; Cunha de Souza E; Besirli CG; Curcio CA; Freund KB
    Retina; 2021 Nov; 41(11):2193-2207. PubMed ID: 34029276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-VEGF Treatment Patterns in Patients With Wet Age-Related Macular Degeneration in Clinical Practice.
    Singh RP; Yu JS; B G; Agashivala N
    Ophthalmic Surg Lasers Imaging Retina; 2021 May; 52(5):263-272. PubMed ID: 34044715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Treatment Patterns in a Population With Neovascular AMD Treated With Anti-VEGF Agents.
    Urbano CA; Maatouk C; Greenlee T; Chen A; Conti TF; Briskin I; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2021 Apr; 52(4):190-198. PubMed ID: 34039184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.
    Okada M; Wong TY; Mitchell P; Eldem B; Talks SJ; Aslam T; Daien V; Rodriguez FJ; Gale R; Barratt J; Finger RP; Loewenstein A
    JAMA Ophthalmol; 2021 Jul; 139(7):769-776. PubMed ID: 34081099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brolucizumab vs aflibercept and ranibizumab for neovascular age-related macular degeneration: a cost-effectiveness analysis.
    Yu JS; Carlton R; Agashivala N; Hassan T; Wykoff CC
    J Manag Care Spec Pharm; 2021 Jun; 27(6):743-752. PubMed ID: 34057392
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study.
    Sim SY; Ghulakhszian A; Minocha A; Ramcharan D; Nokhostin S; Cheong-Leen R; George S; Posner E; Dinah C
    Clin Ophthalmol; 2021; 15():2089-2097. PubMed ID: 34045845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Patients With DME With Good Visual Acuity in Routine Clinical Practice.
    Hentati F; Melo AGR; Greenlee TE; Muste J; Chen AX; Conti TF; Hom GL; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2021 May; 52(5):247-256. PubMed ID: 34044713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EYLEA as First-line Treatment in Wet Age-related Macular Degeneration: An Expert Panel Discussion.
    Retina; 2021 Jun; 41(Suppl 1):S1-S8. PubMed ID: 34036951
    [No Abstract]   [Full Text] [Related]  

  • 13. Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Core JQ; Pistilli M; Daniel E; Grunwald JE; Toth CA; Jaffe GJ; Hua P; Martin DF; Ying GS; Maguire MG;
    Ophthalmol Retina; 2021 Oct; 5(10):962-974. PubMed ID: 34126249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world.
    Llorente-González S; Hernandez M; González-Zamora J; Bilbao-Malavé V; Fernández-Robredo P; Saenz-de-Viteri M; Barrio-Barrio J; Rodríguez-Cid MJ; Donate J; Ascaso FJ; Gómez-Ramírez AM; Araiz J; Armadá F; Ruiz-Moreno Ó; Recalde S; García-Layana A;
    Acta Ophthalmol; 2022 Mar; 100(2):e521-e531. PubMed ID: 34085771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid.
    Bilgic A; Kodjikian L; Vasavada S; Jha S; Srivastava S; Sudhalkar A; Mathis T
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Angermann R; Huber AL; Nowosielski Y; Salcher S; Gasser T; Seifarth C; Kralinger MT; Zehetner C
    Retina; 2022 Mar; 42(3):503-510. PubMed ID: 34731094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration.
    Holekamp NM; Sadda S; Sarraf D; Guymer R; Hill L; Blotner S; Spicer G; Gune S
    Am J Ophthalmol; 2022 Jan; 233():8-17. PubMed ID: 34289338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD).
    Patel P; Sheth V
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Monés et al.: Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER (Ophthalmology. 2021;128:1050-1059).
    Shukla D
    Ophthalmology; 2021 Sep; 128(9):e47. PubMed ID: 34053734
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiopoietins as Potential Targets in Management of Retinal Disease.
    Khanani AM; Russell MW; Aziz AA; Danzig CJ; Weng CY; Eichenbaum DA; Singh RP
    Clin Ophthalmol; 2021; 15():3747-3755. PubMed ID: 34511878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.